Moreover, the correlations between CRAR parameters and mortality risk remained robust across cancer types, such as breast cancer, prostate cancer, gastrointestinal cancer and lymphatic and haematopoietic cancer, although several associations became marginally non-significant (adjusted p value range: 0.05–0.06, online supplemental tables 31–35 ).
← all excerpts
Wearable device-measured circadian rest-activity rhythm with mortality risk in patients with cancer.
1
—
—